Screening method for targeting zinc amino acid chelate metabolism gene based on Crispr whole genome library
By constructing intestinal epithelial cell lines with zinc transport dysfunction, and combining CRISPR-Cas9 technology and flow cytometry, amino acid chelating zinc metabolism genes were screened out. This overcame the shortcomings of existing screening methods and enabled efficient screening and application in the development of products related to improving zinc metabolism.
Patent Information
- Application Number
- CN202511905371.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-17
- Publication Date
- 2026-05-12
AI Technical Summary
Existing technologies lack efficient and specific methods for screening amino acid chelate zinc metabolism genes, which limits the in-depth research and development of related technologies and the promotion and application of products.
A single-gene knockout cell line of intestinal epithelial cells with zinc transport dysfunction was constructed. A whole-genome knockout library was constructed using CRISPR-Cas9 technology. Combined with zinc source treatment and fluorescent dye labeling, cells with differential zinc transport were sorted by flow cytometry. Whole-genome DNA was extracted and bioinformatics analysis was performed to identify genes for amino acid chelation zinc metabolism.
We have achieved high-throughput screening of amino acid chelation zinc-specific metabolic genes, obtained a Zn metabolism regulatory gene library, and developed feed additives and nutritional supplements for improving zinc nutrition status in animals and humans, as well as drugs for treating zinc metabolism-related diseases.